Lilly licenses Insilico's AI drug discovery platform in a deal worth up to $2.75B, signaling a shift in how novel ...

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

Hong Kong-listed InSilico sad the deal could be valued at as much as $2.75 billion.

Semarion has secured new funding to expand its cell-based drug discovery platform, supporting manufacturing scale-up, ...

In this webinar, Dr. Johann Stojko, experienced biophysicist at Novalix, will present integrated workflows that combine ...

Regina Barzilay is a School of Engineering Distinguished Professor of AI & Health in the department of computer science and the AI faculty lead at MIT Jameel Clinic. She develops machine learning ...

By James Amoh Jnr, GNA Special Correspondent, London, United KingdomLondon (UK), March 30, GNA – Across laboratories ...

CHENGDU, China--(BUSINESS WIRE)--HitGen and Fierce Biotech jointly release the Whitepaper: Advancing Drug Discovery through DNA-Encoded Library (DEL) Technology today. This whitepaper will provide the ...

BullFrog AI (BFRG) stock jumped 106% after announcing a drug discovery deal with a top-5 pharma firm targeting major ...

Cell membrane chromatography (CMC) is an innovative bioaffinity technique that utilises immobilised cell membranes to replicate the native configuration and function of membrane proteins. This ...

Get the latest digital health news from MobiHealthNews daily and weekly delivered to your inbox.